Abirtega™ (abiraterone acetate tablets – CivicaScript) — Cigna
Salivary Gland Tumors
Initial criteria
- Patient age ≥ 18 years
- Medication is used in combination with prednisone
- Patient has androgen receptor-positive (AR+) recurrent, unresectable, or metastatic tumor
- Medication is used in combination with a gonadotropin-releasing hormone (GnRH) analog
Approval duration
1 year